Transition Metal Catalysis for Pharmaceutical Intermediates and APIs
DOI:
https://doi.org/10.2533/000942905777676966Keywords:
Asymmetric hydrogenation, Carbonylation, Custom synthesis, Suzuki couplingAbstract
Rohner AG, a medium-sized Swiss company, has moved from toll manufacturing of building blocks and starting materials to the custom manufacturing of intermediates and APIs for the life science industry. Therefore, Rohner AG has expanded its technology portfolio to new technologies such as transition metal catalysis. Examples for asymmetric hydrogenation, Suzuki coupling and carbonylation are provided. In addition, the necessary changes in equipment and project management are presented and discussed.Downloads
Published
2005-01-01
Issue
Section
Scientific Articles
License
Copyright (c) 2005 Swiss Chemical Society
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
A. F. Indolese, D. Wasescha, T. Eisele, C. Bucher, Chimia 2005, 59, 22, DOI: 10.2533/000942905777676966.